Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
smoking cessation
Biotech
Mira seeks to buy Skny for obesity, smoking cessation asset
Mira is trying to buy Skny Pharmaceuticals in a deal that would give it control of a preclinical prospect and add $5 million to its bank balance.
Nick Paul Taylor
Mar 24, 2025 10:08am
Lilly is 'looking closely into' GLP-1 cessation impact
Jun 9, 2023 10:25am
Achieve's anti-smoking drug beats placebo in 2nd phase 3
May 23, 2023 9:00am
Pfizer to promote Alex Therapeutics' smoking cessation app
Jan 31, 2022 10:38am
Using Pfizer’s smoking-cessation drug Chantix to control neurons
Mar 14, 2019 2:00pm
Achieve climbs on data from smoking cessation clinical trial
Feb 22, 2019 10:40am
